Literature DB >> 22114878

4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies.

Marzia Perluigi1, Raffaella Coccia, D Allan Butterfield.   

Abstract

SIGNIFICANCE: Among different forms of oxidative stress, lipid peroxidation comprises the interaction of free radicals with polyunsaturated fatty acids, which in turn leads to the formation of highly reactive electrophilic aldehydes. Among these, the most abundant aldehydes are 4-hydroxy-2-nonenal (HNE) and malondialdehyde, while acrolein is the most reactive. HNE is considered a robust marker of oxidative stress and a toxic compound for several cell types. Proteins are particularly susceptible to modification caused by HNE, and adduct formation plays a critical role in multiple cellular processes. RECENT ADVANCES: With the outstanding progress of proteomics, the identification of putative biomarkers for neurodegenerative disorders has been the main focus of several studies and will continue to be a difficult task. CRITICAL ISSUES: The present review focuses on the role of lipid peroxidation, particularly of HNE-induced protein modification, in neurodegenerative diseases. By comparing results obtained in different neurodegenerative diseases, it may be possible to identify both similarities and specific differences in addition to better characterize selective neurodegenerative phenomena associated with protein dysfunction. Results obtained in our laboratory and others support the common deregulation of energy metabolism and mitochondrial function in neurodegeneration. FUTURE DIRECTIONS: Research towards a better understanding of the molecular mechanisms involved in neurodegeneration together with identification of specific targets of oxidative damage is urgently required. Redox proteomics will contribute to broaden the knowledge in regard to potential biomarkers for disease diagnosis and may also provide insight into damaged metabolic networks and potential targets for modulation of disease progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22114878      PMCID: PMC3449441          DOI: 10.1089/ars.2011.4406

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  214 in total

Review 1.  Down syndrome and beta-amyloid deposition.

Authors:  Elizabeth Head; Ira T Lott
Journal:  Curr Opin Neurol       Date:  2004-04       Impact factor: 5.710

2.  Oxidative stress and protein oxidation in the brain of water drinking and alcohol drinking rats administered the HIV envelope protein, gp120.

Authors:  Ashok K Singh; Shveta Gupta; Yin Jiang
Journal:  J Neurochem       Date:  2007-12-06       Impact factor: 5.372

3.  Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Authors:  D P Devanand; G Pradhaban; X Liu; A Khandji; S De Santi; S Segal; H Rusinek; G H Pelton; L S Honig; R Mayeux; Y Stern; M H Tabert; M J de Leon
Journal:  Neurology       Date:  2007-03-13       Impact factor: 9.910

Review 4.  Lipid peroxidation and neurodegenerative disease.

Authors:  Tanea T Reed
Journal:  Free Radic Biol Med       Date:  2011-06-30       Impact factor: 7.376

5.  Some cerebral proteins and enzyme systems in Alzheimer's presenile and senile dementia.

Authors:  W Op den Velde; F C Stam
Journal:  J Am Geriatr Soc       Date:  1976-01       Impact factor: 5.562

6.  Down syndrome: molecular mapping of the congenital heart disease and duodenal stenosis.

Authors:  J R Korenberg; C Bradley; C M Disteche
Journal:  Am J Hum Genet       Date:  1992-02       Impact factor: 11.025

7.  Effects of 4-hydroxynonenal on isolated hepatocytes. Studies on chemiluminescence response, alkane production and glutathione status.

Authors:  E Cadenas; A Müller; R Brigelius; H Esterbauer; H Sies
Journal:  Biochem J       Date:  1983-08-15       Impact factor: 3.857

Review 8.  The role of polyunsaturated fatty acids in restoring the aging neuronal membrane.

Authors:  Shlomo Yehuda; Sharon Rabinovitz; Ralph L Carasso; David I Mostofsky
Journal:  Neurobiol Aging       Date:  2002 Sep-Oct       Impact factor: 4.673

9.  Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.

Authors:  Tanea Reed; Marzia Perluigi; Rukhsana Sultana; William M Pierce; Jon B Klein; Delano M Turner; Raffaella Coccia; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2008-01-05       Impact factor: 5.996

10.  Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice.

Authors:  Dairin Kieran; Bernadett Kalmar; James R T Dick; Joanna Riddoch-Contreras; Geoffrey Burnstock; Linda Greensmith
Journal:  Nat Med       Date:  2004-03-21       Impact factor: 53.440

View more
  67 in total

1.  Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease.

Authors:  Fabio Di Domenico; Gilda Pupo; Cesare Mancuso; Eugenio Barone; Francesca Paolini; Andrea Arena; Carla Blarzino; Frederick A Schmitt; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 2.  Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies.

Authors:  Aaron M Swomley; Sarah Förster; Jierel T Keeney; Judy Triplett; Zhaoshu Zhang; Rukhsana Sultana; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2013-10-09

3.  Thiamine deficiency induces endoplasmic reticulum stress and oxidative stress in human neurons derived from induced pluripotent stem cells.

Authors:  Xin Wang; Mei Xu; Jacqueline A Frank; Zun-Ji Ke; Jia Luo
Journal:  Toxicol Appl Pharmacol       Date:  2017-02-11       Impact factor: 4.219

Review 4.  Intake of ω-6 Polyunsaturated Fatty Acid-Rich Vegetable Oils and Risk of Lifestyle Diseases.

Authors:  Tetsumori Yamashima; Tsuguhito Ota; Eishiro Mizukoshi; Hiroyuki Nakamura; Yasuhiko Yamamoto; Mitsuru Kikuchi; Tatsuya Yamashita; Shuichi Kaneko
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

5.  Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment.

Authors:  Y Zhao; S Miriyala; L Miao; M Mitov; D Schnell; S K Dhar; J Cai; J B Klein; R Sultana; D A Butterfield; M Vore; I Batinic-Haberle; S Bondada; D K St Clair
Journal:  Free Radic Biol Med       Date:  2014-03-12       Impact factor: 7.376

6.  Structure Annotation and Quantification of Wheat Seed Oxidized Lipids by High-Resolution LC-MS/MS.

Authors:  David Riewe; Janine Wiebach; Thomas Altmann
Journal:  Plant Physiol       Date:  2017-08-11       Impact factor: 8.340

7.  Reactive intermediates: molecular and MS-based approaches to assess the functional significance of chemical-protein adducts.

Authors:  Terrence J Monks; Serrine S Lau
Journal:  Toxicol Pathol       Date:  2012-12-06       Impact factor: 1.902

8.  A role for the p75 neurotrophin receptor in axonal degeneration and apoptosis induced by oxidative stress.

Authors:  Bradley R Kraemer; John P Snow; Peter Vollbrecht; Amrita Pathak; William M Valentine; Ariel Y Deutch; Bruce D Carter
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

Review 9.  The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.

Authors:  D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-07-01       Impact factor: 7.376

10.  Basal brain oxidative and nitrative stress levels are finely regulated by the interplay between superoxide dismutase 2 and p53.

Authors:  Eugenio Barone; Giovanna Cenini; Fabio Di Domenico; Teresa Noel; Chi Wang; Marzia Perluigi; Daret K St Clair; D Allan Butterfield
Journal:  J Neurosci Res       Date:  2015-08-06       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.